HLA-C and neoplasm: EZH2 is overexpressed in PCs, contributing to tumor initiation and progression, and negatively regulating interferon-stimulated genes, including Th1-type chemokines, immune checkpoint molecules, and the major histocompatibility complex (MHC) [158].